Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.8K Sell
2,236
-88
-4% -$2.23K 0.01% 181
2026
Q1
$48.6K Sell
2,324
-26,125
-92% -$611K 0.01% 173
2025
Q4
$565K Sell
28,449
-3,296
-10% -$55.7K 0.15% 91
2025
Q3
$481K Sell
31,745
-14,307
-31% -$164K 0.13% 116
2025
Q2
$489K Sell
46,052
-171
-0.4% -$1.43K 0.16% 116
2025
Q1
$351K Sell
46,223
-2,160
-4% -$17.6K 0.13% 132
2024
Q4
$392K Sell
48,383
-3,238
-6% -$29K 0.13% 128
2024
Q3
$474K Sell
51,621
-1,954
-4% -$15.8K 0.16% 126
2024
Q2
$485K Sell
53,575
-908
-2% -$7.88K 0.19% 119
2024
Q1
$381K Sell
54,483
-257
-0.5% -$1.5K 0.14% 132
2023
Q4
$302K Hold
54,740
0.11% 140
2023
Q3
$267K Sell
54,740
-2
-0% -$10 0.11% 145
2023
Q2
$263K Buy
+54,742
New +$268K 0.1% 149

Other funds holding HBM

Bard Associates's HBM Position: Q2 2026 in Review

Bard Associates reduced its Hudbay (HBM) stake by 3.8% in Q2 2026, selling an estimated $2.23K and leaving 2,236 shares worth $52.8K. The position accounts for 0.01% of the portfolio, ranked #181.

Bard Associates first reported a position in HBM in Q2 2023 and has held it in 13 quarters since. The position peaked at $565K in Q4 2025. 320 funds tracked by Wall St. Rank hold HBM as of Q2 2026.

  • Bard Associates held 2,236 shares of Hudbay worth $52.8K as of Q2 2026.
  • Bard Associates sold 88 Hudbay shares in Q2 2026, an estimated $2.23K.
  • Hudbay made up 0.01% of Bard Associates's portfolio in Q2 2026, its #181 holding.
  • Bard Associates first reported a position in Hudbay in Q2 2023 and has held it in 13 quarters since.
  • Bard Associates's Hudbay position peaked at $565K in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Hudbay as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.